Effects of bisphosphonate derivatives on macrophage function

Area of Science:

• Immunology
• Pharmacology
• Cell Biology

Background:

• Macrophages play a crucial role in the innate immune system.
• Bisphosphonates (BPs) are a class of drugs primarily used to treat bone diseases.
• The immunomodulatory effects of bisphosphonates, particularly on macrophage function, require further investigation.

Purpose of the Study:

• To evaluate the effects of three distinct bisphosphonates (BPs) on key rat peritoneal macrophage functions.
• To assess the impact of 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP), 6-amino-1-hydroxylidene-1,1-bisphosphonate (AHHexBP), and chloromethylenebisphosphonate (Cl2MBP) on phagocytosis, lysosomal enzyme release, and superoxide anion production.

Main Methods:

• Rat peritoneal macrophages were isolated and treated with varying concentrations of the three bisphosphonates.
• Phagocytic activity was assessed using sheep red blood cells (SRBC) and latex beads.
• Lysosomal enzyme (beta-glucuronidase) release was measured using ionophore A23187 stimulation.
• Superoxide anion production was evaluated following phorbol myristate acetate (PMA) stimulation.

Main Results:

• AHBuBP demonstrated a concentration-dependent inhibition of SRBC and latex bead phagocytosis.
• AHHexBP and Cl2MBP exhibited weak inhibitory effects on phagocytosis.
• All three bisphosphonates inhibited phorbol myristate acetate-stimulated superoxide anion production.
• AHBuBP and AHHexBP significantly inhibited beta-glucuronidase release from ionophore-stimulated macrophages compared to Cl2MBP.

Conclusions:

• Bisphosphonates exhibit differential effects on rat peritoneal macrophage functions.
• AHBuBP possesses significant immunomodulatory properties, inhibiting phagocytosis and lysosomal enzyme release.
• These findings suggest potential roles for bisphosphonates beyond bone resorption, impacting macrophage-mediated immune responses.